Type 2 drug also effective at weight loss in non diabetics

The SURMOUNT-1 trial of tirpazetide for obesity just published their peer-reviewed results,a s anticipated in the prelim release: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

Extremely effective: 22%+ weight loss at 72 weeks, with 15mg once weekly. Some gastro side effects, mainly just during dosage ramp.

1654428144571.png
 
Back
Top